|
Real-time Estimate
Cboe BZX
15:36:02 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 0.5700 USD | -0.61% |
|
-13.68% | -64.17% |
| 09-20 | Outlook Therapeutics, Inc.(NasdaqCM:OTLK) added to S&P Global BMI Index | CI |
| 08-27 | Outlook Therapeutics, Inc. Announces CFO Changes, Effective September 1, 2026 | CI |
Company Valuation: Outlook Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 380.5 | 275.9 | 57.51 | 126.3 | 47.08 | 139.6 | - | - |
| Change | - | -27.49% | -79.15% | 119.63% | -62.73% | 196.52% | - | - |
| Enterprise Value (EV) | 380.5 | 275.9 | 57.51 | 126.3 | 47.08 | 139.6 | 139.6 | 139.6 |
| Change | - | -27.49% | -79.15% | 119.63% | -62.73% | 196.52% | 0% | 0% |
| P/E | -6.2x | -3.94x | -0.92x | -1.32x | -0.59x | -0.99x | -2.65x | 6.37x |
| PBR | 71.9x | 29.6x | - | - | - | - | - | - |
| PEG | - | 0.3x | 0x | 0.1x | 0x | 0x | 0x | -0x |
| Capitalization / Revenue | - | - | - | - | 33.3x | 205x | 3.17x | 0.82x |
| EV / Revenue | - | - | - | - | 0x | 205x | 3.17x | 0.82x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -2.63x | -4.09x | 1.74x |
| EV / FCF | - | -0x | -0x | - | - | -3.58x | -12.7x | 1.03x |
| FCF Yield | - | -20.5% | -74.7% | - | - | -27.9% | -7.88% | 96.7% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -7 | -6.2 | -4.8 | -4.06 | -1.79 | -0.58 | -0.2167 | 0.09 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 1.413 | 0.6827 | 44.07 | 170.7 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -51.73 | -63.07 | -53.13 | -71.7 | -67.06 | -53.11 | -34.16 | 80.01 |
| Net income 1 | -53.16 | -66.05 | -58.98 | -75.37 | -62.42 | -65.1 | -44.43 | 20.8 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 43.4000 | 24.4000 | 4.4200 | 5.3400 | 1.0600 | 0.5735 | 0.5735 | 0.5735 |
| Nbr of stocks (in thousands) | 8,767 | 11,307 | 13,012 | 23,656 | 44,420 | 243,448 | - | - |
| Announcement Date | 12/22/21 | 12/29/22 | 12/22/23 | 12/27/24 | 12/19/25 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.99x | - | - | - | 140M | |
| 21.73x | 7.77x | 15.61x | 1.37% | 74.46B | |
| 31.25x | 9.01x | 28.06x | 0.04% | 60.14B | |
| 33.64x | 6.03x | 18.07x | 0.97% | 48.15B | |
| 34.63x | 3.34x | 14.4x | -.--% | 44.25B | |
| -21.16x | 229.18x | -22.81x | -.--% | 43.99B | |
| 47.94x | 5.54x | 30.43x | -.--% | 41.61B | |
| 26.89x | 7.76x | 19.96x | 0.42% | 29.97B | |
| 33.91x | 7.26x | 18.84x | -.--% | 29.31B | |
| -70.02x | 13.44x | -68.51x | -.--% | 24.93B | |
| Average | 13.78x | 32.15x | 6.01x | 0.31% | 39.69B | |
| Weighted average by Cap. | 19.57x | 31.88x | 10.24x | 0.41% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- OTLK Stock
- Valuation Outlook Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
